The incidence of invasive mycoses is increasing, especially among patients who are
immunocompromised or hospitalized with serious underlying diseases. Such infections may …

Since the 1990s, opportunistic fungal infections have emerged as a substantial cause of
morbidity and mortality in profoundly immunocompromised patients. Hypercortisolaemic …

Aspergillus species have emerged as an important cause of life-threatening infections in
immunocompromised patients. This expanding population is composed of patients with …

This report updates, expands, and replaces the previously published CDC" Guideline for
Prevention of Nosocomial Pneumonia". The new guidelines are designed to reduce the …

Background Invasive fungal infections are an important cause of morbidity and mortality after
allogeneic hematopoietic stem-cell transplantation. Methods In an international …

Background. With use of data from the Prospective Antifungal Therapy (PATH) Alliance
registry, we performed this multicenter, prospective, observational study to assess the …

The incidence of postengraftment invasive aspergillosis (IA) in hematopoietic stem cell
transplant (HSCT) recipients increased during the 1990s. We determined risks for IA and …

Aspergillus infections are occurring with an increasing frequency in transplant recipients.
Notable changes in the epidemiologic characteristics of this infection have occurred; these …

There has been an overall increase in fungal healthcare–associated infections (HAIs) that is
likely a consequence of the advances in medical and surgical therapies. The wider use of …

High-dose granulocyte transfusion therapy has been available for 20 years, yet its clinical
efficacy has never been conclusively demonstrated. We report here the results of RING …